Gunnar Danielsson has more than 25 years of experience from the field of clinical research within the pharmaceutical industry. He has held various positions covering monitoring, project leadership and auditing as well as process implementation. The work has been carried out both within local Market Companies as well as Corporate Headquarters in Sweden, UK and US. Between 2003 and 2014 Gunnar held the position as GCP Inspector at the Swedish Medical Products Agency. During this time Gunnar conducted a vast number of inspections in Sweden and internationally. He has during this time been an active member of EMA GCP Inspectors Working Group and has been directly involved in the development of a variety of guidelines and reflection papers. Gunnar has also given numerous lectures and presentation both locally and internationally within the field of clinical development. Gunnar retired in 2014 from the Medical Products Agency and is now working as a consultant.